Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Modakafusp alfa (DHD80805)

Host species:Humanized
Isotype:IgG4-kappa
Applications:Research Grade Biosimilar
Expression system:Mammalian Cells
Overview

Catalog No.

DHD80805

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Humanized

Isotype

IgG4-kappa

Clonality

Monoclonal

Target

Cyclic ADP-ribose hydrolase 1, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase, T10, 2'-phospho-cyclic-ADP-ribose transferase, CD38, ADPRC 1, ADP-ribosyl cyclase 1, 2'-phospho-ADP-ribosyl cyclase

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P28907

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

TAK-573, TEV-48573, CAS: 2254522-19-3

Clone ID

Modakafusp alfa

Data Image
  • SDS-PAGE
    SDS PAGE for Modakafusp alfa
References

Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation, PMID: 31807265

Dornase alfa for cystic fibrosis, PMID: 30187450

Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial, PMID: 32723804

Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease, PMID: 29921734

Dornase Alfa, PMID: 32310478

Dornase alfa (Pulmozyme), PMID: 22990660

Lutropin alfa, PMID: 18627209

A pharmacokinetic evaluation of ropeginterferon alfa-2b in the treatment of polycythemia vera, PMID: 33118413

Epoetin Alfa, PMID: 30000431

Asfotase alfa for hypophosphatasia, PMID: 30670890

Susoctocog Alfa: A Review in Acquired Haemophilia A, PMID: 27098420

Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent, PMID: 30813754

Interference of Asfotase Alfa in Immunoassays Employing Alkaline Phosphatase Technology, PMID: 32445383

Darbepoetin alfa, PMID: 11735636

Efmoroctocog alfa for haemophilia A, PMID: 30670892

Octocog alfa, plasma/albumin-free method, PMID: 16392876

Peginterferon Alfa, PMID: 29999705

XM17 Follitropin Alfa (Ovaleap(®)): A Review in Reproductive Endocrine Disorders, PMID: 27342604

Vestronidase Alfa, PMID: 30000015

Dornase alfa for cystic fibrosis, PMID: 27043279

Ropeginterferon alfa-2 b for the therapy of polycythemia vera, PMID: 32942868

Dornase Alfa, PMID: 29999662

Alglucosidase Alfa, PMID: 30000880

Trenonacog alfa for prophylaxis, on-demand and perioperative management of hemophilia B, PMID: 29172774

Turoctocog alfa (NovoEight®)--from design to clinical proof of concept, PMID: 24797664

Dornase Alfa for Non-Cystic Fibrosis Pediatric Pulmonary Atelectasis, PMID: 24811400

Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease, PMID: 31363309

Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A, PMID: 25848213

Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology, PMID: 24630271

Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiency, PMID: 27376161

Interferon-alfa in the treatment of chronic hepatitis B, PMID: 15313664

Darbepoetin alfa: a novel erythropoiesis-stimulating protein, PMID: 12973399

Spotlight on taliglucerase alfa in the treatment of pediatric patients with type 1 Gaucher disease, PMID: 29388611

Agalsidase alfa: a review of its use in the management of Fabry disease, PMID: 22946754

Pharmacology of darbepoetin alfa, PMID: 17526547

Darbepoetin alfa: in patients with chemotherapy-related anaemia, PMID: 12749734

Interview with Dr Ghassan K Abou-Alfa, PMID: 27993088

Darbepoetin alfa: a novel erythropoiesis-stimulating protein, PMID: 12086553

Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction, PMID: 21815699

Peginterferon alfa-2a: a review of approved and investigational uses, PMID: 15336466

Epoetin alfa. Clinical evolution of a pleiotropic cytokine, PMID: 14769622

Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease, PMID: 29471850

Stability of Turoctocog Alfa, a Recombinant Factor VIII Product, during Continuous Infusion In Vitro, PMID: 33195971

Epoetin alfa in cancer patients: evidence-based guidelines, PMID: 11728799

Epoetin alfa versus darbepoetin alfa in chemotherapy-related anemia, PMID: 16332942

Real-world utilization of darbepoetin alfa in cancer chemotherapy patients, PMID: 28814194

Epoetin alfa as a supportive measure in hematologic malignancies, PMID: 12447849

Dornase alfa, PMID: 18031106

Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia, PMID: 12783618

Epoetin alfa use in gynecology. Past, present and future, PMID: 11396388

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Modakafusp alfa [DHD80805]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only